146 related articles for article (PubMed ID: 37682815)
1. Fatty Liver Index and mortality after myocardial infarction: A prospective analysis in the Alpha Omega Cohort.
Heerkens L; van Kleef LA; de Knegt RJ; Voortman T; Geleijnse JM
PLoS One; 2023; 18(9):e0287467. PubMed ID: 37682815
[TBL] [Abstract][Full Text] [Related]
2. Serum uric acid is related to liver and kidney disease and 12-year mortality risk after myocardial infarction.
Heerkens L; van Westing AC; Voortman T; Kardys I; Boersma E; Geleijnse JM
Front Endocrinol (Lausanne); 2023; 14():1240099. PubMed ID: 37886649
[TBL] [Abstract][Full Text] [Related]
3. Fatty liver index and development of cardiovascular disease in Koreans without pre-existing myocardial infarction and ischemic stroke: a large population-based study.
Kim JH; Moon JS; Byun SJ; Lee JH; Kang DR; Sung KC; Kim JY; Huh JH
Cardiovasc Diabetol; 2020 May; 19(1):51. PubMed ID: 32359355
[TBL] [Abstract][Full Text] [Related]
4. The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study.
Lee CH; Han KD; Kim DH; Kwak MS
Front Endocrinol (Lausanne); 2021; 12():638615. PubMed ID: 33776934
[TBL] [Abstract][Full Text] [Related]
5. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study.
Fresneda S; Abbate M; Busquets-Cortés C; López-González A; Fuster-Parra P; Bennasar-Veny M; Yáñez AM
Biol Sex Differ; 2022 Nov; 13(1):64. PubMed ID: 36333736
[TBL] [Abstract][Full Text] [Related]
6. Fatty Liver Index as a proxy for non-alcoholic fatty liver disease and the risk of stroke and coronary heart disease: The Suita Study.
Arafa A; Kashima R; Matsumoto C; Kokubo Y
J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107495. PubMed ID: 38000108
[TBL] [Abstract][Full Text] [Related]
7. Association of fatty liver index with the risk of incident cardiovascular disease and acute myocardial infarction.
Olubamwo OO; Virtanen JK; Voutilainen A; Kauhanen J; Pihlajamäki J; Tuomainen TP
Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1047-1054. PubMed ID: 29912803
[TBL] [Abstract][Full Text] [Related]
8. Young adults with nonalcoholic fatty liver disease, defined using the fatty liver index, can be at increased risk of myocardial infarction or stroke.
Chung GE; Cho EJ; Yoo JJ; Chang Y; Cho Y; Park SH; Han K; Jeong SM; Yoon KW; Shin DW; Yu SJ; Kim YJ; Yoon JH
Diabetes Obes Metab; 2022 Mar; 24(3):465-472. PubMed ID: 34726318
[TBL] [Abstract][Full Text] [Related]
9. The associations of hepatic steatosis and fibrosis using fatty liver index and BARD score with cardiovascular outcomes and mortality in patients with new-onset type 2 diabetes: a nationwide cohort study.
Park J; Kim G; Kim BS; Han KD; Kwon SY; Park SH; Lee YB; Jin SM; Kim JH
Cardiovasc Diabetol; 2022 Apr; 21(1):53. PubMed ID: 35429980
[TBL] [Abstract][Full Text] [Related]
10. Association of NAFLD with cardiovascular disease and all-cause mortality: a large-scale prospective cohort study based on UK Biobank.
Ma W; Wu W; Wen W; Xu F; Han D; Lyu J; Huang Y
Ther Adv Chronic Dis; 2022; 13():20406223221122478. PubMed ID: 36159632
[TBL] [Abstract][Full Text] [Related]
11. Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes.
Giorda C; Forlani G; Manti R; Mazzella N; De Cosmo S; Rossi MC; Nicolucci A; Russo G; Di Bartolo P; Ceriello A; Guida P;
Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 28032449
[TBL] [Abstract][Full Text] [Related]
12. Fatty liver index is an independent risk factor for all-cause mortality and major cardiovascular events in type 1 diabetes: an 11-year observational study.
Garofolo M; Lucchesi D; Giambalvo M; Aragona M; Bertolotto A; Campi F; Bianchi C; Francesconi P; Marchetti P; Del Prato S; Penno G
Cardiovasc Diabetol; 2024 Feb; 23(1):85. PubMed ID: 38419065
[TBL] [Abstract][Full Text] [Related]
13. Sugar-sweetened beverages, low/no-calorie beverages, fruit juice and non-alcoholic fatty liver disease defined by fatty liver index: the SWEET project.
Naomi ND; Ngo J; Brouwer-Brolsma EM; Buso MEC; Soedamah-Muthu SS; Pérez-Rodrigo C; Harrold JA; Halford JCG; Raben A; Geleijnse JM; Serra-Majem L; Feskens EJM
Nutr Diabetes; 2023 Apr; 13(1):6. PubMed ID: 37085478
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease and the incidence of myocardial infarction: A cohort study.
Sinn DH; Kang D; Chang Y; Ryu S; Cho SJ; Paik SW; Song YB; Pastor-Barriuso R; Guallar E; Cho J; Gwak GY
J Gastroenterol Hepatol; 2020 May; 35(5):833-839. PubMed ID: 31512278
[TBL] [Abstract][Full Text] [Related]
15. Association between nonalcoholic fatty liver disease and cardiovascular disease revealed after comprehensive control of metabolic risk factors: a nationwide population-based study in Korea.
Seo BS; Roh JH; Lee JH; Lee H; Min Kim Y; Yoon YH; Kim M; Kim YG; Park GM; Park JH; Seong IW
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e375-e382. PubMed ID: 33731579
[TBL] [Abstract][Full Text] [Related]
16. Antibody against apolipoprotein-A1, non-alcoholic fatty liver disease and cardiovascular risk: a translational study.
Pagano S; Bakker SJL; Juillard C; Vossio S; Moreau D; Brandt KJ; Mach F; Dullaart RPF; Vuilleumier N
J Transl Med; 2023 Oct; 21(1):694. PubMed ID: 37798764
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes.
Li M; Zhao Z; Qin G; Chen L; Lu J; Huo Y; Chen L; Zeng T; Xu M; Chen Y; Wang T; Wang S; Xu Y; Shi L; Tang X; Su Q; Yu X; Yan L; Wan Q; Chen G; Gao Z; Wang G; Shen F; Luo Z; Zhang Y; Liu C; Wang Y; Hu R; Ye Z; Wu S; Deng H; Yang T; Li Q; Qin Y; Mu Y; Zhao J; Ning G; Bi Y; Xu Y; Wang W
Metabolism; 2021 Nov; 124():154874. PubMed ID: 34517014
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver is associated with increased risk of irritable bowel syndrome: a prospective cohort study.
Wu S; Yuan C; Yang Z; Liu S; Zhang Q; Zhang S; Zhu S
BMC Med; 2022 Aug; 20(1):262. PubMed ID: 35989356
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Path of Mediterranean Diet, Non-Alcoholic Fatty Liver Disease (NAFLD) and Inflammation towards 10-Year Cardiovascular Disease (CVD) Risk: The ATTICA Study 10-Year Follow-Up (2002-2012).
George ES; Georgousopoulou EN; Mellor DD; Chrysohoou C; Pitsavos C; Panagiotakos DB
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
